NGNE EBITDA Growth
Neurogene Inc · EBITDA Growth
NGNE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-32.77%period ending
NGNE TTM EBITDA YoY % (4.02% → -32.77%)
Year-over-year change
High-resolution chart · PNG
NGNE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -32.7697% | |
| -22.8851% | |
| -21.38% | |
| -64.1832% | |
| -83.4338% | |
| -106.2643% | |
| -117.7805% | |
| -1.9031% | |
| 6.2282% | |
| 26.4104% | |
| 39.3458% | |
| 12.6972% | |
| 20.0051% | |
| 12.7738% | |
| 6.839% | |
| -0.1677% | |
| -37.2809% | |
| -56.7672% | |
| -85.7038% | |
| -105.9591% | |
| 49.1217% | |
| 50.4646% | |
| 54.5991% | |
| 58.8986% | |
| -282.8073% | |
| -294.1772% | |
| -119.3882% | |
| -54.1455% | |
| 44.5128% | |
| 66.0695% | |
| 37.0633% | |
| 4.8629% | |
| 4.0245% |